万物皆可偶联:抗体片段偶联药物(FDC) ADC(antibody-drug conjugates),即抗体药物偶联物,是近年相当热门的一种治疗肿瘤的新技术,是将具有靶向性质的抗体和强细胞毒性的药物偶联而成的一种新型抗肿瘤药物,俗称“生物导弹”。ADC药物市场前景广阔,但技术上也还存在一些问...
statins were used in combination tablets within 6 months after myocardial infarction. The study clearly showed that combination tablets can benefit patients. The NEPTUNO study is a real-world clinical study of patients treated wit...
Moreover, the incidence of adverse drug reactions in the whole treatment process did not increase, which is worthy of active promotion and application. Keywords: Tuberculosis; Diabetes Mellitus; Fixed Dose; Separate Tablets; Treatment Effect; Adverse Reactions 结核病(TB)是全球第二大传染病杀手.根据...
dapagliflozin and saxagliptin in drug-naïve patients with type 2 diabetes: a randomised controlled trial. OP 51 "With a little help from my friends": therapies and combinations. EASD Annual Meeting 2023.
近日，Antikor Biopharma的首席科学家、首席执行官兼运营官Mahendra Deonaria博士与亿胜生物科技（01061.HK）首席科学家薛琦博士，于华人抗体协会旗下期刊、牛津大学出版社出版的《Antibody Therapeutics》（《抗体药物》）杂志，发表了题为“Tackling solid tumour therapy with small-format drug conjugates”（片段偶联药物...
近日,Antikor Biopharma的首席科学家、首席执行官兼运营官Mahendra Deonaria博士与亿胜生物科技(01061.HK)首席科学家薛琦博士,于华人抗体协会旗下期刊、牛津大学出版社出版的《Antibody Therapeutics》(《抗体药物》)杂志,发表了题为“Tackling solid tumour therapy with small-format drug conjugates”(片段偶联药物治疗实...
【摘要】目的:探讨固定剂量复合制剂(fixed-dose combination,FDC)治疗肺结核的不良反应(adverse drug reactions,ADR)发生情况,监测不良反应发生,对肺结核控制工作具有重要意义。方法:选取 2017 年 1 月至 2018 年 12 月在勐海县人民医院感染科住院接受 FDC 抗结核治疗的肺结核患者 535 人,回顾分析其临床资料。结果...
Drug laws need to be amended to ensure the safety and effectiveness of medicines marketed in India.PatriciaMcGettiganPeterRoderickRushikeshMahajanAbhayKadamAllyson MPollockPLoS medicineMcGettigan P, Roderick P, Mahajan R, Kadam A, Pollock AM. Use of Fixed Dose Combination (FDC) Drugs in India: ...
The National Pharmaceuticals Pricing Authority (NPPA) has granted exemption to Sun Pharmaceuticals from the provisions of DPCO, 2013 for its FDC drug silver sulfadiazine IP (Nanonized) 0.5% w/w and chlorhexidine gluconate 0.2% w/w topical cream for a period of five years from the date of com...
NeoSphere、APHINITY及CLEOPATRA研究表明,相较于曲妥珠单抗(H)+化疗(CT),帕妥珠单抗(P)+H+CT可给HER2阳性早期和转移性乳腺癌患者带来更多获益。然而,静脉输注(IV)P+H尚存在一些不足,如:输液和观察时间长、医疗资源占用较多以及感染和血栓形成风险较高等。